A Flawed Study Shows How Little We Understand Crispr's Effects
A Flawed Study Shows How Little We Understand Crispr's Effects
Science, Spoken · SpokenLayer
April 4, 20185m 13s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Biotech has been betting big on Crispr, the gene-editing technique that promises to snip away some of humanity’s worst diseases. But last May, a small case study suggested the much-hyped technology might actually be quite dangerous—and pop went the Crispr bubble, briefly tanking shares of Crispr companies like Editas Medicine, Intellia Therapeutics, and Crispr Therapeutics.
Learn about your ad choices: dovetail.prx.org/ad-choices